BusinessPCI Synthesis Celebrates Key Milestones Including 4th Consecutive Year of Double-Digit Growth, 2 Commercial Approvals and a New Office in San DiegoBy Nasdaq OMXFeb 27, 2018, 2:15 PM UTC
BusinessPCI Synthesis’ Ed Price Joins SOCMA’s Board of GovernorsBy Nasdaq OMXJan 11, 2018, 2:15 PM UTC
BusinessPCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018By Nasdaq OMXDec 18, 2017, 2:15 PM UTC
